The molecular biology of pancreatic adenocarcinoma: translational challenges and clinical perspectives | Signal Transduction and Targeted Therapy
Frontiers | Detection of Circulating Tumor Cells in Resectable Pancreatic Ductal Adenocarcinoma: A Prospective Evaluation as a Prognostic Marker
Insight of pancreatic cancer: recommendations for improving its therapeutic efficacy in the next decade | Journal of Pancreatology
Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers | Science Translational Medicine
Identification of candidate diagnostic and prognostic biomarkers for pancreatic carcinoma - eBioMedicine
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data - eClinicalMedicine
Dynamic profiling of immune microenvironment during pancreatic cancer development suggests early intervention and combination strategy of immunotherapy - eBioMedicine
Trefoil factor(s) and CA19.9: A promising panel for early detection of pancreatic cancer - eBioMedicine
Frontiers | Clinical Impact of Molecular Subtyping of Pancreatic Cancer
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis | Scientific Reports
Flow-diagram of patient identification. Patients with a diagnosis of... | Download Scientific Diagram
Frontiers | Stroma Involvement in Pancreatic Ductal Adenocarcinoma: An Overview Focusing on Extracellular Matrix Proteins
Frontiers | Predictive Biomarkers for a Personalized Approach in Resectable Pancreatic Cancer
Tumor markers in pancreatic cancer: 2013. | Semantic Scholar
Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags | British Journal of Cancer
Prognostic Role of Carbohydrate Antigen 19 to 9 in Predicting Survival of Patients With Pancreatic Cancer: A Meta-Analysis - Yong-Ming Kang, Hao Wang, Ran Li, Gu Pan, 2021
Cureus | Molecular Markers of Pancreatic Cancer: A 10-Year Retrospective Review of Molecular Advances | Article
Biosensors | Free Full-Text | An Exosomal miRNA Biomarker for the Detection of Pancreatic Ductal Adenocarcinoma
Early detection of pancreatic cancer - The Lancet Gastroenterology & Hepatology
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report. | Semantic Scholar
Diagnostics | Free Full-Text | Early Detection of Pancreatic Cancer: Role of Biomarkers in Pancreatic Fluid Samples
IJMS | Free Full-Text | Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer
Microenvironmental Determinants of Pancreatic Cancer | Physiological Reviews
What Makes a Pancreatic Cancer Resectable? | American Society of Clinical Oncology Educational Book
Cancers | Free Full-Text | Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review
Cancers | Free Full-Text | Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives
Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer - ScienceDirect
Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis - eBioMedicine
